Biotech Industry News

A collection of Biotech latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.

scmp.com - Julie Zhang - China's biotech boom drives surge in home-grown innovative drug approvals
China's biotech boom drives surge in home-grown innovative drug approvals
South China Morning Post

Home-grown innovative drugs make up most of the medicines China's drug regulator has approved for sale so far this year, underscoring the country's biotech boom. Of the 19 innovative drugs cleared by the National Medical Products Administration…

smh.com.au - James Pearson - Perth biotech duo Avicena, Syngenis forge biosecurity shield
Perth biotech duo Avicena, Syngenis forge biosecurity shield
The Sydney Morning Herald

Two Perth biotechnology companies are positioning themselves at the front line of Australia's future biosecurity defence, combining cutting-edge molecular diagnostics with automated large-scale testing to tackle infectious disease threats before…

seekingalpha.com - Albert Anthony - Natera: A Growing Biotech, After Recent FDA Approval And Q1 Revenue Results (NASDAQ:NTRA)
Natera: A Growing Biotech, After Recent FDA Approval And Q1 Revenue Results (NASDAQ:NTRA)
Seeking Alpha

Albert Anthony is the pen name of a business author on Amazon and his newest book is 'How To Pick Stocks: 8 Steps For Long-Term Investing with Fundamental & Technical Analysis,' now available as a 2026 edition paperback and Kindle ebook in several…

fool.com - Jake Lerch - Investment Firm Closes Out Entire $18.1 Million Position in Biotech Stock, According to Latest SEC Filing
Investment Firm Closes Out Entire $18.1 Million Position in Biotech Stock, According to Latest SEC Filing
The Motley Fool

On May 14, 2026, Rhenman & Partners Asset Management AB disclosed it sold out its entire stake in Vera Therapeutics (VERA +1.06%), unloading 420,000 shares in an estimated $18.10 million trade based on the quarterly average price. According to a…

send2press.com - Industrial SalesLeads Inc - 99 New Pharmaceutical Biotechnology and Healthcare Projects Drive Major Facility Investments in April 2026
99 New Pharmaceutical Biotechnology and Healthcare Projects Drive Major Facility Investments in April 2026
Send2Press Newswire

JACKSONVILLE, Fla., May 27, 2026 (SEND2PRESS NEWSWIRE) — Industrial manufacturing activity remained strong in April 2026, led by sustained investment from the pharmaceutical, medical device, biotechnology, and healthcare sectors. Industrial…

fool.com - Cory Renauer - Harvest Investment Services Dumps 356,000 Adaptive Biotechnologies (ADPT) Shares Worth $5.7 Million
Harvest Investment Services Dumps 356,000 Adaptive Biotechnologies (ADPT) Shares Worth $5.7 Million
The Motley Fool

In its SEC filing dated May 14, 2026, Harvest Investment Services, LLC reported selling its entire stake of 356,114 shares in Adaptive Biotechnologies (ADPT +1.80%) during the first quarter. The estimated value of the shares sold was ~$5.67…

seekingalpha.com - Petri Dish Reports - Voyager Technologies: Latest Space Defence Player To Capitalise On Momentum (NYSE:VOYG)
Voyager Technologies: Latest Space Defence Player To Capitalise On Momentum (NYSE:VOYG)
Seeking Alpha

Voyager Technologies is positioned for upside if it transitions from R&D-heavy contracts to scaled, repeatable production in defense and space platforms. VOYG's record $275.3M backlog, 1.3x book-to-bill, and raised FY26 guidance (39–53%…

seekingalpha.com - Calamos Investments - Calamos U.S. Opportunities Strategy Q1 2026 Commentary
Calamos U.S. Opportunities Strategy Q1 2026 Commentary
Seeking Alpha

For the quarter ended March 31, 2025, the portfolio returned -3.59% (gross of fees) and -3.77% (net of fees) compared with the S&P 500 Index's return of -4.33%. The portfolio benefited from favorable security selection and an average underweight…

marketbeat.com - UBS Group AG Purchases 203,203 Shares of Vir Biotechnology, Inc. $VIR
UBS Group AG Purchases 203,203 Shares of Vir Biotechnology, Inc. $VIR
MarketBeat

UBS Group AG increased its position in shares of Vir Biotechnology, Inc. (NASDAQ:VIR - Free Report) by 94.6% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 417,965 shares…

seekingalpha.com - Petri Dish Reports - Pony AI 1Q26: 145% Growth--And It May Be Just Getting Started (NASDAQ:PONY)
Pony AI 1Q26: 145% Growth--And It May Be Just Getting Started (NASDAQ:PONY)
Seeking Alpha

Pony AI Inc. delivered a standout 1Q26, beating revenue and earnings expectations with 145% YOY revenue growth and a raised full-year outlook. PONY's Robotaxi segment is the primary growth engine, with revenue up ~400% YOY and fare-based revenue…

globenewswire.com - Zealand Pharma - Zealand Pharma to participate in the Jefferies Global Healthcare Conference
Zealand Pharma to participate in the Jefferies Global Healthcare Conference
GlobeNewswire

Press release – No. 11 / 2026 Zealand Pharma to participate in the Jefferies Global Healthcare Conference Copenhagen, Denmark, May 27, 2026 - Zealand Pharma A/S (Nasdaq: ZEAL) (CVR-no. 20045078), a biotechnology company transforming the…

forbes.com - Jordan Henry - Navigating AI Ethics At The Biosecurity Frontier
Navigating AI Ethics At The Biosecurity Frontier
Forbes

Jordan W. Henry, MHA, MAOL, CAIE, FAHM Veritas AI Consulting Firm. In my two decades spanning AI ethics and governance, biosecurity policy, public health preparedness and response, and emergency management—including specialized training in…

news-medical.net - Tecan establishes direct sales and specialist lab automation service operations in India
Tecan establishes direct sales and specialist lab automation service operations in India
News-Medical

Tecan, a global provider of laboratory automation and solutions, today announced the launch of direct operations in India, including a dedicated local sales and service team based in Gurugram, near New Delhi. The launch, marked with a…

globenewswire.com - MitoRx Therapeutics Limited - MitoRx Therapeutics to present new preclinical data on MTRX31, its novel mitochondrial-targeted small molecule at the American Diabetes Association's 2026 Scientific Sessions
MitoRx Therapeutics to present new preclinical data on MTRX31, its novel mitochondrial-targeted small molecule at the American Diabetes Association's 2026 Scientific Sessions
GlobeNewswire

Poster to be presented at ADA 2026 on weight loss induced by MTRX31 in an industry-standard preclinical model of obesity MitoRx Chief Scientific Officer Xavier Jacq to also participate in panel and deliver corporate presentation at Sachs Associates…

nasa.gov - Robotics, Science Underway as Cosmonauts Prep for Wednesday Spacewalk
Robotics, Science Underway as Cosmonauts Prep for Wednesday Spacewalk
NASA

Robotics controllers wrapped up a weekend of swapping scientific hardware packed inside the SpaceX Dragon cargo spacecraft's trunk for installation on the International Space Station. Meanwhile, the Expedition 74 crew is continuing its…

Receive a Daily briefing on Biotech Industry News

Get Started